KIORA PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months
KIORA PHARMACEUTICALS, INC. (KPRX) had Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months of $173.13 thousand as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths · last filed 2026-03-25
- 2025-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $173.13K.
- 2024-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $26.75K.
- 2023-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $53.97K.
- 2021-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $133.34K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months |
|---|---|
| 2025-12-31 | $173.13K 10-K · filed 2026-03-25 |
| 2024-12-31 | $26.75K 10-K · filed 2025-03-25 |
| 2023-12-31 | $53.97K 10-K · filed 2024-03-25 |
| 2021-12-31 | $133.34K 10-K/A · filed 2022-07-07 |
| 2021-09-30 | $55.13K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $110.38K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $77.22K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $51.56K 10-K · filed 2021-03-25 |
| 2020-09-30 | $29.35K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |